A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape

Journal of Immunology

Volumn 168, Issue 9, 2002, Pages 4772-4780

  Wiendl, Heinz ^a   Mitsdoerffer, Meike ^a   Hofmeister, Valeska ^a   Wischhusen, Jörg ^a   Bornemann, Antje ^a   Meyermann, Richard ^a   Weiss, Elisabeth H ^a   Melms, Arthur ^a   Weller, Michael ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; HLA G ANTIGEN; HLA G1 ANTIGEN; HLA G5 ANTIGEN; MESSENGER RNA; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; CANCER IMMUNOLOGY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GLIOMA; GLIOMA CELL; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; TUMOR ESCAPE;

EID: 0036569659     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.168.9.4772     Document Type: Article

References (42)

1. The failure of current immunotherapy for malignant glioma: Tumor-derived TGF-β, T-cell apoptosis, and the immune privilege of the brain
2. Anti-Fas/APO-1 Ab-mediated apoptosis of cultured human glioma cells: Induction and modulation of sensitivity by cytokines
3. CD95 ligand: Lethal weapon against malignant glioma?
4. Loss of HLA haplotype and B locus down-regulation in melanoma cell lines
5. A class I antigen, HLA-G, expressed in human trophoblasts
6. Identification of a thymic epithelial cell subset sharing expression of the class Ib HLA-G molecule with fetal trophoblasts
7. Expression of HLA-G in human mononuclear phagocytes and selective induction by IFN-γ
8. Muscle fibers in inflammatory myopathies and cultured myoblasts express the nonclassical major histocompatibility antigen HLA-G
9. HLA-G expression in melanoma: A way for tumor cells to escape from immunosurveillance
10. HLA-G and HLA-E: Fundamental and pathophysiological aspects
11. Cell-cell adhesion mediated by CD8 and human histocompatibility leukocyte antigen G, a nonclassical major histocompatibility complex class 1 molecule on cytotrophoblasts
12. Nonclassical HLA-G molecules are classical peptide presenters
13. Peptide presentation and NK inhibition by HLA-G
14. The role of peptide presentation in the physiological function of HLA-G
15. The α1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: Is HLA-G the public ligand for natural killer cell inhibitory receptors?
16. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells
17. Multiple receptors for HLA-G on human natural killer cells
18. HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes
19. + cells by interacting with CD8
20. Topoisomerase I inhibitors for human malignant glioma: Differential modulation of p53, p21, bax and bcl-2 expression and of CD95-mediated apoptosis by camptothecin and β-lapachone
21. 32P-based hybridizations
22. The HLA-E gene encodes two differentially regulated transcripts and a cell surface protein
23. Complex expression pattern of the TNF region gene LST1 through differential regulation, initiation, and alternative splicing
24. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
25. Expression and regulation of HLA-G in human glioma cell lines
26. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis
27. HLA-G1 co-expression boosts the HLA class I-mediated NK lysis inhibition
28. + T-lymphocytes
29. HLA-G has a concentration-dependent effect on the generation of an allo-CTL response
30. Soluble HLA class I molecules induce apoptosis in alloreactive cytotoxic T lymphocytes
31. + T cell regulatory mechanism
32. Heterogeneity of HLA-G gene transcription and protein expression in malignant melanoma biopsies
33. Increased expression of human histocompatibility leukocyte antigen-G in colorectal cancer cells
34. HLA-G protein expression is not induced during malignant transformation
35. Tumor-specific up-regulation of the nonclassical class I HLA-G antigen expression in renal carcinoma
36. Expression analysis of classic and non-classic HLA molecules before interferon α-2b treatment of melanoma-2b
37. Melanomas and melanoma cell lines do not express HLA-G, and the expression cannot be induced by IFN-γ treatment
38. HLA-G expression by tumors
39. Expression of HLA-G in human tumors is not a frequent event
40. Looking for HLA-G expression in human tumours
41. Reaction patterns of monoclonal Abs to HLA-G in human tissues and on cell lines: A comparative study
42. HLA-G, -E, -F preworkshop: Tools and protocols for analysis of non-classical class I genes transcription and protein expression